Close

Form SC 13D Electromed, Inc. Filed by: Summers Value Fund LP

July 19, 2021 4:41 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. )1

Electromed, Inc.

(Name of Issuer)

Common Stock, par value $0.01 per share

(Title of Class of Securities)

285409108

(CUSIP Number)

ANDREW SUMMERS

SUMMERS VALUE PARTNERS LLC

90 Madison Street, Suite 303

Denver, Colorado 80206

(303) 502-3339

 

RYAN NEBEL

OLSHAN FROME WOLOSKY LLP

1325 Avenue of the Americas

New York, New York 10019

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

July 8, 2021

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

 

 

 

1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No. 285409108

  1   NAME OF REPORTING PERSON  
         
        Summers Value Fund LP  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        WC  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        DELAWARE  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         320,224  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          320,224  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        320,224  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        3.7%  
  14   TYPE OF REPORTING PERSON  
         
        PN  

  

2

CUSIP No. 285409108

  1   NAME OF REPORTING PERSON  
         
        SVP Deal Fund 1 LP  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        WC  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        DELAWARE  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         166,758  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          166,758  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        166,758  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        1.9%  
  14   TYPE OF REPORTING PERSON  
         
        PN  

  

3

CUSIP No. 285409108

 

  1   NAME OF REPORTING PERSON  
         
        Summers Value Partners GP LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        AF  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        DELAWARE  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         320,224  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          320,224  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        320,224  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        3.7%  
  14   TYPE OF REPORTING PERSON  
         
        OO  

  

4

CUSIP No. 285409108

 

  1   NAME OF REPORTING PERSON  
         
        SVP Deal Fund 1 GP LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        AF  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        DELAWARE  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         166,758  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          166,758  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        166,758  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        1.9%  
  14   TYPE OF REPORTING PERSON  
         
        OO  

  

5

CUSIP No. 285409108

 

  1   NAME OF REPORTING PERSON  
         
        Summers Value Partners LLC  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        AF  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        DELAWARE  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         486,982  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          486,982  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        486,982  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.6%  
  14   TYPE OF REPORTING PERSON  
         
        OO, IA  

  

6

CUSIP No. 285409108

 

  1   NAME OF REPORTING PERSON  
         
        Andrew Summers  
  2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
        (b) ☐
           
  3   SEC USE ONLY    
           
           
  4   SOURCE OF FUNDS  
         
        AF  
  5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
       
           
  6   CITIZENSHIP OR PLACE OF ORGANIZATION  
         
        USA  
NUMBER OF   7   SOLE VOTING POWER  
SHARES          
BENEFICIALLY         - 0 -  
OWNED BY   8   SHARED VOTING POWER  
EACH          
REPORTING         486,982  
PERSON WITH   9   SOLE DISPOSITIVE POWER  
         
          - 0 -  
    10   SHARED DISPOSITIVE POWER  
           
          486,982  
  11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
         
        486,982  
  12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
       
           
  13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
        5.6%  
  14   TYPE OF REPORTING PERSON  
         
        IN, HC  

  

7

CUSIP No. 285409108

The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”).

Item 1.Security and Issuer.

This statement relates to the common stock, par value $0.01 per share (the “Shares”), of Electromed, Inc., a Minnesota corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 500 Sixth Avenue NW, New Prague, Minnesota 56071.

Item 2.Identity and Background.

(a)       This statement is filed by:

(i)Summers Value Fund LP, a Delaware limited partnership (“Summers Value Fund”);
(ii)SVP Deal Fund 1 LP, a Delaware limited partnership (“SVP Fund”);
(iii)Summers Value Partners GP LLC, a Delaware limited liability company (“Summers Value GP”), which serves as the general partner of Summers Value Fund;
(iv)SVP Deal Fund 1 GP LLC, a Delaware limited liability company (“SVP GP”), which serves as the general partner of SVP Fund;
(v)Summers Value Partners LLC, a Delaware limited liability company (“Summers Value Partners”), which serves as the investment manager of each of Summers Value Fund and SVP Fund; and
(vi)Andrew Summers, as the Managing Member of each of Summers Value GP, SVP GP and Summers Value Partners.

Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is party to that certain Joint Filing Agreement, as further described in Item 6. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.

(b)       The address of the principal office of each of the Reporting Persons is 90 Madison Street, Suite 303, Denver, Colorado 80206.

(c)       The principal business of each of Summers Value Fund and SVP Fund is investing in securities. The principal business of Summers Value GP is serving as the general partner of Summers Value Fund. The principal business of SVP GP is serving as the general partner of SVP Fund. The principal business of Summers Value Partners is serving as the investment manager of each of Summers Value Fund and SVP Fund. The principal occupation of Mr. Summers is serving as the Managing Member of each of Summers Value GP, SVP GP and Summers Value Partners.

(d)       No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

8

CUSIP No. 285409108

(e)       No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f)       Summers Value Fund, SVP Fund, Summers Value GP, SVP GP and Summers Value Partners are organized under the laws of the State of Delaware. Mr. Summers is a citizen of the United States of America.

Item 3.Source and Amount of Funds or Other Consideration.

The Shares purchased by each of Summers Value Fund and SVP Fund were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 320,224 Shares beneficially owned by Summers Value Fund is approximately $2,030,220, including brokerage commissions. The aggregate purchase price of the 166,758 Shares beneficially owned by SVP Fund is approximately $1,866,422, including brokerage commissions.

Item 4.Purpose of Transaction.

The Reporting Persons purchased the Shares based on the Reporting Persons’ belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

The Reporting Persons have engaged, and intend to continue to engage, in communications with the Issuer’s Board of Directors (the “Board”) and management team regarding means to enhance shareholder value.

No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board of the Issuer, engaging in discussions with shareholders of the Issuer and others about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer concerning changes to the capital allocation strategy, capitalization, ownership structure, Board structure (including Board composition) or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.

Item 5.Interest in Securities of the Issuer.

(a)       The aggregate percentage of Shares reported owned by each person named herein is based upon 8,637,420 Shares outstanding as of May 7, 2021, which is the total number of Shares outstanding as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 11, 2021.

9

CUSIP No. 285409108

As of the date hereof, Summers Value Fund directly beneficially owned 320,224 Shares, constituting approximately 3.7% of the Shares outstanding. Summers Value GP, as the general partner of Summers Value Fund, may be deemed to beneficially own the 320,224 Shares owned by Summers Value Fund, constituting approximately 3.7% of the Shares outstanding.

As of the date hereof, SVP Fund directly beneficially owned 166,758 Shares, constituting approximately 1.9% of the Shares outstanding. SVP GP, as the general partner of SVP Fund, may be deemed to beneficially own the 166,758 Shares owned by Summers Value Fund, constituting approximately 1.9% of the Shares outstanding.

Summers Value Partners, as the investment manager of Summers Value Fund and SVP Fund, may be deemed to beneficially own the 486,982 Shares owned in the aggregate by Summers Value Fund and SVP Fund, constituting approximately 5.6% of the Shares outstanding. Mr. Summers, as the Managing Member of each of Summers Value GP, SVP GP and Summers Value Partners, may be deemed to beneficially own the 486,982 Shares owned in the aggregate by Summers Value Fund and SVP Fund, constituting approximately 5.6% of the Shares outstanding.

The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

(b)       By virtue of their respective relationships to Summers Value Fund, each of Summers Value Fund, Summers Value GP, Summers Value Partners and Mr. Summers may be deemed to share the power to vote and dispose of the Shares reported owned by Summers Value Fund.

By virtue of their respective relationships to SVP Fund, each of SVP Fund, SVP GP, Summers Value Partners and Mr. Summers may be deemed to share the power to vote and dispose of the Shares reported owned by SVP Fund.

(c)       Schedule A annexed hereto lists all transactions in securities of the Issuer by the Reporting Persons during the past 60 days. All of such transactions were effected in the open market unless otherwise noted therein.

(d)       No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.

(e)Not applicable.
Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

On July 19, 2021, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer to the extent required by applicable law. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

10

CUSIP No. 285409108

Item 7.Material to be Filed as Exhibits.
99.1Joint Filing Agreement, dated July 19, 2021.

11

CUSIP No. 285409108

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: July 19, 2021

  Summers Value Fund LP
   
  By: Summers Value Partners GP LLC
General Partner
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  SVP Deal Fund 1 LP
   
  By: SVP Deal Fund 1 GP LLC
General Partner
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  Summers Value Partners GP LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  SVP Deal Fund 1 GP LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  Summers Value Partners LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

 

/s/ Andrew Summers

  Andrew Summers

 

12

CUSIP No. 285409108

SCHEDULE A

Transactions in Securities of the Issuer During the Past 60 Days

Nature of the Transaction

Securities

Purchased/(Sold)

Price Per

Security($)

Date of

Purchase/Sale

 

Summers Value Fund LP

 

Purchase of Common Stock 100 11.1400 06/25/2021
Purchase of Common Stock 100 11.7200 07/09/2021
Purchase of Common Stock 388 11.7300 07/09/2021

 

SVP Deal Fund 1 LP

 

Purchase of Common Stock 2,687 10.8800 06/15/2021
Purchase of Common Stock 5,000 10.6900 06/15/2021
Purchase of Common Stock 5,000 10.5600 06/15/2021
Purchase of Common Stock 5,000 10.6100 06/15/2021
Purchase of Common Stock 2,537 10.6300 06/15/2021
Purchase of Common Stock 2 10.6500 06/15/2021
Purchase of Common Stock 2,461 10.6800 06/15/2021
Purchase of Common Stock 1,692 10.4700 06/15/2021
Purchase of Common Stock 348 10.5500 06/16/2021
Purchase of Common Stock 4,652 10.6000 06/16/2021
Purchase of Common Stock 5,000 10.6500 06/16/2021
Purchase of Common Stock 5,000 10.6000 06/16/2021
Purchase of Common Stock 5,000 10.5800 06/16/2021
Purchase of Common Stock 10 10.5000 06/16/2021
Purchase of Common Stock 2,000 10.5800 06/17/2021
Purchase of Common Stock 3,500 10.6100 06/17/2021
Purchase of Common Stock 3,500 10.5100 06/17/2021
Purchase of Common Stock 100 10.5200 06/17/2021
Purchase of Common Stock 1,900 10.5300 06/17/2021
Purchase of Common Stock 3,000 10.5100 06/17/2021
Purchase of Common Stock 506 10.5100 06/17/2021
Purchase of Common Stock 494 10.5200 06/17/2021
Purchase of Common Stock 3,000 10.5100 06/17/2021
Purchase of Common Stock 5,000 10.5100 06/17/2021
Purchase of Common Stock 600 11.1300 06/25/2021
Purchase of Common Stock 4,000 11.8000 06/25/2021
Purchase of Common Stock 1,000 11.7600 06/25/2021
Purchase of Common Stock 1,000 11.7000 06/25/2021
Purchase of Common Stock 1,000 11.8000 06/25/2021
Purchase of Common Stock 1,000 11.8300 06/25/2021
Purchase of Common Stock 1,000 11.7900 06/25/2021
Purchase of Common Stock 133 11.7300 06/25/2021
Purchase of Common Stock 634 11.2500 07/01/2021
Purchase of Common Stock 1,610 11.3200 07/01/2021
Purchase of Common Stock 256 11.3400 07/01/2021
Purchase of Common Stock 2,500 11.3200 07/01/2021
Purchase of Common Stock 2,107 11.3000 07/01/2021
Purchase of Common Stock 393 11.3900 07/01/2021
Purchase of Common Stock 987 11.3900 07/01/2021
Purchase of Common Stock 1,513 11.4500 07/01/2021
Purchase of Common Stock 2,057 11.4500 07/01/2021
Purchase of Common Stock 443 11.4800 07/01/2021
Purchase of Common Stock 3,000 11.4500 07/01/2021
Purchase of Common Stock 3,000 11.3700 07/01/2021
Purchase of Common Stock 2,500 11.3600 07/01/2021
Purchase of Common Stock 190 11.3500 07/01/2021
Purchase of Common Stock 3,500 11.2400 07/02/2021
Purchase of Common Stock 4 11.3800 07/02/2021
Purchase of Common Stock 1,000 11.3200 07/06/2021
Purchase of Common Stock 3,000 11.4700 07/06/2021
Purchase of Common Stock 2,500 11.4300 07/06/2021
Purchase of Common Stock 2,500 11.5100 07/06/2021
Purchase of Common Stock 2,000 11.5500 07/06/2021
Purchase of Common Stock 1,000 11.5000 07/07/2021
Purchase of Common Stock 1,000 11.4500 07/07/2021
Purchase of Common Stock 1,000 11.5100 07/07/2021
Purchase of Common Stock 317 11.5000 07/07/2021
Purchase of Common Stock 2,183 11.6000 07/07/2021
Purchase of Common Stock 721 11.7600 07/07/2021
Purchase of Common Stock 100 11.8200 07/07/2021
Purchase of Common Stock 215 11.8400 07/07/2021
Purchase of Common Stock 18 11.5500 07/08/2021
Purchase of Common Stock 100 11.6000 07/08/2021
Purchase of Common Stock 10 11.6100 07/08/2021
Purchase of Common Stock 30 11.6500 07/08/2021
Purchase of Common Stock 220 11.6900 07/08/2021
Purchase of Common Stock 2,122 11.7500 07/08/2021
Purchase of Common Stock 2,500 11.7400 07/08/2021
Purchase of Common Stock 2,500 11.6400 07/08/2021
Purchase of Common Stock 100 11.6400 07/08/2021
Purchase of Common Stock 478 11.6100 07/09/2021
Purchase of Common Stock 1,522 11.6600 07/09/2021
Purchase of Common Stock 95 11.5400 07/09/2021
Purchase of Common Stock 200 11.6000 07/09/2021
Purchase of Common Stock 196 11.6800 07/09/2021
Purchase of Common Stock 1,509 11.7100 07/09/2021
Purchase of Common Stock 2,700 11.7900 07/09/2021
Purchase of Common Stock 1,000 11.6200 07/09/2021
Purchase of Common Stock 5 11.7100 07/09/2021
Purchase of Common Stock 16 11.7200 07/09/2021
Purchase of Common Stock 979 11.7500 07/09/2021
Purchase of Common Stock 3,000 11.6200 07/12/2021
Purchase of Common Stock 4 11.7300 07/12/2021
Purchase of Common Stock 261 11.5600 07/13/2021
Purchase of Common Stock 739 11.7300 07/13/2021
Purchase of Common Stock 3,000 11.7300 07/13/2021
Purchase of Common Stock 1,000 11.6300 07/14/2021
Purchase of Common Stock 200 11.6000 07/14/2021
Purchase of Common Stock 66 11.5200 07/14/2021
Purchase of Common Stock 2,434 11.5800 07/14/2021
Purchase of Common Stock 200 11.5900 07/14/2021
Purchase of Common Stock 495 11.6100 07/14/2021
Purchase of Common Stock 1,474 11.6400 07/14/2021
Purchase of Common Stock 331 11.6400 07/14/2021
Purchase of Common Stock 100 11.6400 07/14/2021
Purchase of Common Stock 1,200 11.7000 07/14/2021
Purchase of Common Stock 408 11.7400 07/14/2021
Purchase of Common Stock 101 11.8500 07/16/2021
Purchase of Common Stock 2,399 11.9500 07/16/2021
Purchase of Common Stock 2,500 11.9500 07/16/2021
Purchase of Common Stock 271 11.8500 07/16/2021
Purchase of Common Stock 1,729 11.8600 07/16/2021
Purchase of Common Stock 2,500 11.8000 07/16/2021
Purchase of Common Stock 1,000 11.6200 07/19/2021
Purchase of Common Stock 2,500 11.5100 07/19/2021
Purchase of Common Stock 2,500 11.6600 07/19/2021
Purchase of Common Stock 694 11.5300 07/19/2021

 


Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.01 per share, of Electromed, Inc., a Minnesota corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.

Dated: July 19, 2021

  Summers Value Fund LP
   
  By: Summers Value Partners GP LLC
General Partner
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  SVP Deal Fund 1 LP
   
  By: SVP Deal Fund 1 GP LLC
General Partner
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  Summers Value Partners GP LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  SVP Deal Fund 1 GP LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

  Summers Value Partners LLC
   
  By:

/s/ Andrew Summers

    Name: Andrew Summers
    Title: Managing Member

 

 

 

/s/ Andrew Summers

  Andrew Summers

 



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings

Related Entities

13D